Euclid Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-47,148
| Closed | -$1.57M | – | 165 |
|
|
2016
Q2 | $1.57M | Buy |
47,148
+4,890
| +12% | +$163K | 0.07% | 299 |
|
|
2016
Q1 | $1.24M | Sell |
42,258
-15,810
| -27% | -$465K | 0.05% | 319 |
|
|
2015
Q4 | $1.53M | Buy |
+58,068
| New | +$1.53M | 0.05% | 298 |
|
|
2015
Q3 | – | Sell |
-28,302
| Closed | -$672K | – | 292 |
|
|
2015
Q2 | $672K | Sell |
28,302
-206,478
| -88% | -$4.9M | 0.01% | 370 |
|
|
2015
Q1 | $5.57M | Buy |
+234,780
| New | +$5.57M | 0.1% | 189 |
|
|
2014
Q4 | – | Sell |
-326,880
| Closed | -$5.57M | – | 415 |
|
|
2014
Q3 | $5.57M | Buy |
326,880
+21,840
| +7% | +$372K | 0.04% | 352 |
|
|
2014
Q2 | $4.36M | Sell |
305,040
-54,234
| -15% | -$776K | 0.03% | 382 |
|
|
2014
Q1 | $4.44M | Buy |
359,274
+94,620
| +36% | +$1.17M | 0.03% | 337 |
|
|
2013
Q4 | $2.9M | Sell |
264,654
-21,120
| -7% | -$232K | 0.02% | 460 |
|
|
2013
Q3 | $3.32M | Buy |
285,774
+59,424
| +26% | +$690K | 0.03% | 384 |
|
|
2013
Q2 | $2.54M | Buy |
+226,350
| New | +$2.54M | 0.03% | 413 |
|